Incyte (INCY) EPS (Diluted) Growth (3y) (2013 - 2026)
Incyte (INCY) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 147.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 147.95% |
| Dec 31, 2025 | 127.24% |
| Sep 30, 2025 | 61.16% |
| Jun 30, 2025 | 41.34% |
| Mar 31, 2025 | 67.32% |
| Dec 31, 2024 | -27.80% |
| Sep 30, 2024 | -12.73% |
| Jun 30, 2024 | -71.34% |
| Mar 31, 2024 | 45.69% |
| Dec 31, 2023 | 9.01% |
| Sep 30, 2023 | 134.52% |
| Jun 30, 2023 | -11.85% |
| Mar 31, 2023 | 26.60% |
| Dec 31, 2022 | -37.07% |
| Sep 30, 2022 | -5.12% |
| Jun 30, 2022 | 14.23% |
| Mar 31, 2022 | -28.76% |
| Dec 31, 2021 | 99.39% |
| Sep 30, 2021 | 82.24% |
| Jun 30, 2021 | 40.29% |